Home FAQ About SMI Join SMI Links SMI Members Reg & Tech Events & Conferences

What is SMI?

What are self-medication products?

What are the characteristic of OTC medicines?

What conditions do they treat?

What responsibility does the consumer have?

What Is SMI?

The New Zealand Self-Medication Industry Association Inc (the ‘SMI’) is the national trade association representing manufacturers, marketers and distributors of a wide range of products, generally available “over-the-counter” (OTC) and mainly for use in self-medication by consumers.

These industry products include non-prescription (OTC) medicines, dietary supplements and any other complementary healthcare product that meets New Zealand legislative requirements.

What are self-medication products?

These include a wide range of medicines better known as ‘Over-The-Counter’ or OTC medicines because New Zealand consumers may purchase them ‘over-the-counter’ without a doctor’s prescription.

Depending upon the classification of the medicine, consumers can expect to receive additional professional advice primarily from a qualified pharmacist.

Before marketing, these medicines have been subject to an evaluation process by Medsafe (part of the Ministry of Health) to ensure that safety, quality and effectiveness criteria have been met. Label claims which may form the basis of subsequent consumer advertising are also subject to scrutiny before these products can receive ‘consent to market’ by the regulatory authority.

OTC medicines assist in the containment of health care costs.

They provide a familiar, cost-effective and convenient method of dealing with the symptoms of well-recognised ailments through self-medication.

  

Characteristics of OTC Medicines

These medicines are characterised by their..

bullet

effective treatment of well-recognised and in many cases, self-limiting ailments

bullet

broad margins of safety

bullet

availability through pharmacies, supermarkets and other approved retail outlets, where the consumer can make an individual responsible decision.

bullet

comprehensive consumer information particularly labelling to ensure safe and effective use.

bullet

relatively low cost which is borne by the individual and not taxpayer subsidised or reimbursed. 

Conditions Treated

Conditions commonly treated with self-medication products include…

bullet

common colds, coughs, flu’, sore throat, and other respiratory infections

bullet

nasal congestion

bullet

pain, including headaches, muscular/ joint aches and pains, period pain, migraine

bullet

upset stomach, indigestion, diarrhoea and constipation

bullet

hay fever, sinus conditions and allergies

bullet

hair and scalp conditions

bullet

 insect bites and stings

bullet

corns, warts and callouses

bullet

cold sore and chilblains

bullet

vaginal thrush

bullet

foot infections

bullet

minor eye and ear problems

bullet

gum/teething conditions

bullet

acne and other skin conditions

bullet

minor cuts and scratches

bullet

worm infestations

bullet

platelet aggregation inhibition

bullet

smoking cessation

An increasingly important product sector for self-medication are those that either help maintain good health or enhance the general well-being and  health status of consumers.

These include dietary supplements, vitamin and mineral products and other complementary healthcare products and sun protection products that have recognised benefits and can substantiate claims for their effectiveness.

Personal Responsibility

The process of self-medication as part of self care is consistent with the desire of consumers to take greater responsibility for their own health.

Self-medication has become an integral part of health care systems worldwide and self-medication products  are recognised as an essential part of health care delivery.

 

 

 

 

 

 

SMI Code of Practice

 

 

Members Log On